Could your DNA predict thyroid cancer after radiation?
NCT ID NCT04139096
First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time
Summary
This study investigates whether certain DNA variants make people more likely to develop thyroid cancer after receiving radiation therapy as a child. Researchers will compare the genetic profiles of about 30 people who developed thyroid cancer and 30 who did not, all of whom were treated for a skin hemangioma with radiation decades ago. The goal is to understand how genetics interact with radiation exposure to influence cancer risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could identify genetic markers that predict who is most at risk for radiation-induced thyroid cancer, enabling personalized screening and prevention strategies.
- What could go wrong
- This is a small, observational study with only 60 participants, so findings may not apply to broader populations. The results may not lead to immediate clinical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENETIC SUSCEPTIBILITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gustae Roussy
Villejuif, Val de Marne, 948000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple tool may help thyroid cancer patients avoid treatment regret
- Drug duo aims to starve thyroid tumors
- Smartphone app could ease neck pain after thyroid surgery
- New imaging tracer could spot hidden cancers and fibrosis in one scan
- Cancer drug pralsetinib may change how the body processes other medications
- Sharper radiation boost aims to tackle head and neck cancers that return